Jinan Zequan Cross border E-commerce Co., Ltd – Trademark Portfolio
Entity Type: 99
Jinan Zequan Cross border E-commerce Co., Ltd owns a portfolio of 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as UCMORX, HRYONIE, IERTIOR, and SQUITHAI. Of these, 4 are registered. The portfolio spans 4 Nice Classification classes, led by Class 25 (Clothing) and Class 8 (Hand Tools). Headquartered in Shandong Province.
Laiwu High tech Zone, Jinan City
911, No. 111 Ludongdong Street
Shandong Province 271100 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jinan Zequan Cross border E-commerce Co., Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Jinan Zequan Cross border E-commerce Co., Ltd have?
Jinan Zequan Cross border E-commerce Co., Ltd has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Jinan Zequan Cross border E-commerce Co., Ltd file in?
Jinan Zequan Cross border E-commerce Co., Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 8 (Hand Tools), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 25 covers clothing, footwear, headgear.
What are Jinan Zequan Cross border E-commerce Co., Ltd's most well-known trademarks?
Jinan Zequan Cross border E-commerce Co., Ltd's registered trademark portfolio includes well-known marks such as UCMORX, HRYONIE, IERTIOR, and SQUITHAI. These are among 4 currently registered trademarks in the portfolio.
What is Jinan Zequan Cross border E-commerce Co., Ltd's trademark registration success rate?
Jinan Zequan Cross border E-commerce Co., Ltd has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.